A graphic showing a cross-section of a body with a tumour in a lung.

Lung Cancer Study Day: On-Demand

Available on demand until 24 September 2026

Key information

Delivery type 

On demand

Delivery style 

Online learning

Duration 

1 day 

Experience level 

All

What to expect 

This on-demand study day brings together expert healthcare professionals to explore the rapidly evolving landscape of lung cancer management. As one of the most prevalent and complex malignancies, lung cancer requires coordinated, multidisciplinary care and a strong understanding of emerging diagnostic and treatment approaches.

Through expert-led sessions, this programme explores key aspects of lung cancer care, including screening, treatment pathways and the management of symptoms and treatment-related toxicities. You will gain insight into both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), alongside current research, clinical trials and future developments in the field.

Designed to support professionals working across the patient pathway, this study day highlights patient-centred approaches to care and offers practical insights that can be applied directly in clinical practice. Available on demand, it provides a flexible opportunity to update your knowledge at a time that suits you.

Learning outcomes 

By the end of this study day, you should be able to:

  • Understand current approaches to lung cancer screening and diagnosis
  • Recognise strategies for managing treatment toxicities and complex symptoms
  • Explore evolving treatment pathways for NSCLC and SCLC
  • Gain insight into current research studies, clinical trials and emerging therapies
  • Strengthen your understanding of multidisciplinary, patient-centred lung cancer care

Why choose this programme?

This course offers a comprehensive and flexible update on lung cancer care, bringing together expert insight and the latest developments in the field. It is ideal for professionals looking to strengthen their understanding of treatment pathways, symptom management and emerging therapies.

Who is it for? 

Suitable for:

  • Nurses
  • Allied Health Professionals
  • Specialist Nurses
  • Doctors
  • Student Nurses
  • Anyone with a special interest in, or involvement in, the care of patients with lung cancer

How to book/learn more 

You can book this course on Eventbrite.

Please note: one ticket purchase is equivalent to one CPD certificate. The name on the certificate will match the booking registration.

Not ready to book? Find out more

  • Jackie Hodgetts Image For Block

    Jackie Hodgetts, Clinical Lead Spotlight

    Hear from Jackie Hodgetts, Advanced Practitioner in Melanoma at The Christie, ahead of her session at our upcoming Melanoma Study Day.

    Read more about Jackie Hodgetts, Clinical Lead Spotlight
  • IMG 9698 2 (1)

    Learner voices: Filipa Verdasca

    Meet Filipa Verdasca, Medical Oncology Resident at Unidade Local de Saúde de São José (Lisbon, Portugal) who completed an Obversership in Advanced Immunotherapy and Cell Therapy Team (AICT), supervised by Jon Lim.

    Read more about Learner voices: Filipa Verdasca
  • Christin Hume Hcfwew744z4 Unsplash

    Paterson Programme Impact Report now live

    The Paterson Programme was established within The Christie Institute of Cancer Education to provide psychologically informed coaching, mentoring and professional development support for residents, fellows, specialty doctors and educators working within oncology and related specialties.

    Read more about Paterson Programme Impact Report now live
Christie colleague?

Christie colleague?

Login to your learning zone.

Login to view courses